Hiya @LHI 14
Yes, I'm inclined to agree. Anyone interested in Her-vaxx would surely be interested in taking both Her-vaxx and PD1-vaxx.
The follow on B cell portfolio drugs you mention are actually being developed by Prof Kaumaya, not by the Vienna team. The two most recent papers on PDL1-vaxx (that I am aware of) are:
- https://pubmed.ncbi.nlm.nih.gov/36211807/
- https://www.jove.com/t/65467/magnetic-fluorescent-bead-based-dual-reporter-flow-analysis-pdl1-vaxx
I commented on both at the time, here on HC. The second paper was only available as an abstract when I wrote about it, but the full text is now available.
Cheers
Dave
Hiya @LHI 14Yes, I'm inclined to agree. Anyone interested in...
-
- There are more pages in this discussion • 4,992 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1723946 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 905438 | 6 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |